ECRI Institute’s health technology assessment service released an emerging technology brief concerning digital breast tomosynthesis (3-D mammography). The information is based on ECRI’s technology forecast report, "Digital Breast Tomosynthesis for Screening and Diagnosis of Breast Cancer."

IBA (Ion Beam Applications S.A) announced the release of an exclusive feature that reduces the power consumption of IBA proton therapy 230 MeV isochronous cyclotron (C230) by more than 30 percent. This unique feature helps reduce the overall cost of proton therapy, making it ever more accessible to patients worldwide.

Four World Health Organization (WHO) member states and nine non-governmental organizations (NGOs) co-organized a side event during the 68th session of the World Health Assembly (WHA) entitled “Imaging for Saving Kids - the Inside Story about Patient Safety in Pediatric Radiology." The International Society of Radiology (ISR) was one of the initiators of the side event.

Phase III results of Radiation Therapy Oncology Group (RTOG) 0537 indicate that acupuncture-like, transcutaneous electrical nerve stimulation (ALTENS) may be equally effective as pilocarpine to treat radiation-induced xerostomia (dry mouth). Study results were published in the June 1, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). RTOG 0537 is a phase II/III, multi-center, randomized trial comparing ALTENS with pilocarpine, which is the current standard of treatment for radiation-induced xerostomia.

With the introduction of Elekta's new Leksell Gamma Knife Icon, the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. This latest generation stereotactic radiosurgery system for the brain integrates advanced motion management, dose delivery and imaging technologies, significantly increasing the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon at the 3rd European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona.

Oxford Instruments plc has acquired Medical Imaging Resources Inc. (MIR). MIR specializes in the build, lease and service of mobile medical imaging labs.

The novel Ga-68-PSMA-ligand positron emission tomography/computed tomography (PET/CT) has substantially higher detection rates of prostate-specific membrane antigen (PSMA) in patients with biochemical recurrence after radical prostatectomy, according to a recent study. Discovering a recurrence early can strongly influence further clinical management, so it is especially noteworthy that this hybrid PSMA-ligand identified a large number of positive findings in the clinically important range of low PSA-values (<0.5ng/mL).

Ipsen announced the signature of an agreement to acquire OctreoPharm Sciences, a private German life sciences company developing innovative radioactive-labeled compounds for molecular imaging diagnostics and therapeutic applications. Ipsen plans to maintain the company location and staff to ensure successful transition of know-how and expertise. The company expects to complete its acquisition once closing conditions have been cleared.